Community Healthcare Trust (CHCT) Q2 2026 earnings review
Historic Dividend Cut Signals Pivot to Internal Funding
After a near-decade streak of consecutive quarterly increases, CHCT management finally capitulated to the reality of its cost of capital, slashing the dividend by 31% to $0.33 per share. This is a dramatic reversal of the company's long-standing narrative. The move drops the AFFO payout ratio to ~60% and retains $25-$30M over two years to fund growth. With a depressed stock price halting ATM equity issuance, the company had no choice but to fund its $99M acquisition pipeline through retained earnings and asset sales. While AFFO per share remained stable at $0.56, a stubborn 89.8% occupancy rate and the year-long unresolved geriatric tenant saga highlight the operational execution risks ahead.
🐂 Bull Case
The 31% dividend cut acts as a hard reset, lowering the payout ratio to 60%. Retaining $25-$30M internally immediately reduces reliance on expensive external equity to fund the $99M acquisition pipeline.
Management is actively marketing over $70M in dispositions to cycle out of non-core assets, rolling proceeds into 9-10% yielding properties and 9-12% yielding redevelopment projects.
🐻 Bear Case
The 6-property geriatric behavioral hospital problem remains unsolved. The tenant signed an LOI to sell its operations in July 2025—a full year ago—yet the transaction remains unclosed, dragging on portfolio performance.
Despite a robust strategic presentation targeting 92% occupancy, actual leased occupancy sits at 89.8%, down from 90.7% a year ago. Execution risk on leasing remains high.
⚖️ Verdict: 🔴
Bearish. The dividend cut was a necessary medicine for a broken capital structure, but it destroys the company's primary retail narrative. With occupancy declining YoY and a major tenant issue dragging past the one-year mark, management must prove they can execute on their new strategic plan before the stock deserves a premium.
Key Themes
The Dividend Growth Streak Ends
Reversing. For years, management's primary point of pride on earnings calls was a streak of raising the dividend every single quarter since the IPO. That streak is dead. The Q3 dividend was slashed 31% from $0.48 to $0.33. While this rightsizes the AFFO payout ratio from a burdensome 87% to a healthy 60%, it represents a fundamental break in the company's investment thesis.
Geriatric Tenant Saga Hits the One-Year Mark
Stable but problematic. A tenant operating six geriatric behavioral hospitals has been a known distressed asset since early 2025. Management noted they signed an LOI for the sale of this tenant's operations in July 2025. One year later, the deal is still in the 'drafting phase.' The tenant paid just $0.4M in rent in Q2 (up slightly from $0.3M in Q1, but far below historical norms). Until this is resolved, it remains a severe drag on NOI.
Occupancy Reality Contradicts Growth Narrative
Decelerating. Management launched a new strategic plan targeting 92% leased occupancy over the next 18-24 months. However, the hard data contradicts the optimism: leased occupancy dipped to 89.8% in Q2 2026, down from 90.6% in 25Q4 and 90.7% a year ago. The company needs to reverse this leakage before organic growth can materialize.
Macro Environment Forces Capital Recycling
With the REIT's stock price depressed and cost of equity too high, the ATM program remains completely shut off (zero shares issued in Q2). As a direct result of this macro capital markets constraint, management is relying entirely on capital recycling—marketing over $70M in dispositions to fund accretive growth without diluting shareholders.
High-Yield Acquisition Pipeline
Stable. The company continues to source high-quality assets off-market, maintaining a $99M pipeline under definitive agreement. The expected initial yields of 9% to 10% (with ~2.5% annual escalators) provide a clear path to accretive NOI growth, provided they can successfully fund the closures through their asset sale program.
Internal Reinvestment as the Core Product
CHCT is shifting focus to its internal product—its existing portfolio. By deploying dedicated internal Asset Management, Leasing, and Construction teams, they signed over 100,000 sq. ft. of new leases YTD. Furthermore, they are targeting 9-12% yields on redevelopment and spec suite investments, turning internal optimization into a primary earnings engine.
Other KPIs
Stable. AFFO per share remained flat sequentially at $0.56 and is up from $0.50 in 25Q2. The underlying cash generation of the business remains solid, proving the dividend cut was a capital allocation choice rather than a sign of crashing cash flows.
Stable. The leverage ratio remains virtually unchanged from Q1 (44.0%) and up slightly from 41.6% a year ago. Management remains disciplined, utilizing a fully unsecured $560M debt structure with no maturities before 2028, insulating them from near-term refinancing risks.
Stable. Down sequentially from $5.11M in Q1 2026 and drastically down from the distorted $10.56M in 25Q2 (which included $5.9M in severance charges). Cash G&A remains tightly controlled at roughly 6.8% of total revenue.
Guidance
Accelerating. Management explicitly targeted a climb from the current 89.8% to 92.0% over the next 18-24 months. Achieving this would represent a $6M uplift to Annualized NOI, acting as a massive organic growth lever.
Reversing. Down from $0.48. This reset will retain $25M-$30M in capital over the next two years, permanently altering the yield profile of the stock from ~10.5% (trailing) to a sustainable ~7.2% forward yield.
Stable. The $99M pipeline is projected to close at highly accretive yields, continuing the company's successful strategy of operating in less competitive, off-market non-urban healthcare facilities.
Key Questions
Geriatric Tenant Timeline
It has been over a year since the LOI was signed to transition the six troubled geriatric behavioral hospitals to a new operator. What specific regulatory or financial hurdles are keeping this from closing, and at what point do you seek an alternative path?
Disposition Market Depth
You are relying on $70M in marketed dispositions to fund your $99M acquisition pipeline. Given the current interest rate environment, how deep is the buyer pool for the assets you are shedding, and what happens to the pipeline if those sales fall through?
Leasing Velocity Confidence
You are targeting 92% occupancy over the next 18-24 months, yet occupancy has ticked down year-over-year to 89.8%. What specific leasing pipeline metrics give you confidence in a 220 basis point reversal?